240 related articles for article (PubMed ID: 19199480)
1. Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.
Vu CB; Bemis JE; Disch JS; Ng PY; Nunes JJ; Milne JC; Carney DP; Lynch AV; Smith JJ; Lavu S; Lambert PD; Gagne DJ; Jirousek MR; Schenk S; Olefsky JM; Perni RB
J Med Chem; 2009 Mar; 52(5):1275-83. PubMed ID: 19199480
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new class of glucokinase activators through structure-based design.
Hinklin RJ; Boyd SA; Chicarelli MJ; Condroski KR; DeWolf WE; Lee PA; Lee W; Singh A; Thomas L; Voegtli WC; Williams L; Aicher TD
J Med Chem; 2013 Oct; 56(19):7669-78. PubMed ID: 24015910
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and chemiluminescent high throughput screening for inhibition of acetylcholinesterase activity by imidazo[2,1-b]thiazole derivatives.
Andreani A; Granaiola M; Guardigli M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Roda A
Eur J Med Chem; 2005 Dec; 40(12):1331-4. PubMed ID: 16129518
[TBL] [Abstract][Full Text] [Related]
4. Antihyperglycemic effects of newly synthesized 6,7-bis[2-(substitutedphenyl)-4-oxothiazolidin3yl1 quinoxaline 2,3-(1 FH, 4 H)-diones.
Pawar PY; Bhise SB
Indian J Physiol Pharmacol; 2006; 50(4):431-4. PubMed ID: 17402276
[No Abstract] [Full Text] [Related]
5. Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors.
Andreani A; Burnelli S; Granaiola M; Guardigli M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Rizzoli M; Varoli L; Roda A
Eur J Med Chem; 2008 Mar; 43(3):657-61. PubMed ID: 17624631
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
[TBL] [Abstract][Full Text] [Related]
7. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
[TBL] [Abstract][Full Text] [Related]
8. Substituted tetrahydropyrrolo[2,1-b]oxazol-5(6H)-ones and tetrahydropyrrolo[2,1-b]thiazol-5(6H)-ones as hypoglycemic agents.
Aicher TD; Balkan B; Bell PA; Brand LJ; Cheon SH; Deems RO; Fell JB; Fillers WS; Fraser JD; Gao J; Knorr DC; Kahle GG; Leone CL; Nadelson J; Simpson R; Smith HC
J Med Chem; 1998 Nov; 41(23):4556-66. PubMed ID: 9804695
[TBL] [Abstract][Full Text] [Related]
9. Euglycaemic and biological activities of novel thiazolidine-2,4-dione derivatives.
de Nanteuil G; Herve Y; Duhault J; Espinal J; Boulanger M; Ravel D
Arzneimittelforschung; 1995 Nov; 45(11):1176-81. PubMed ID: 8929235
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
Crane L; Anastassiadou M; El Hage S; Stigliani JL; Baziard-Mouysset G; Payard M; Leger JM; Bizot-Espiard JG; Ktorza A; Caignard DH; Renard P
Bioorg Med Chem; 2006 Nov; 14(22):7419-33. PubMed ID: 16889967
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes.
Kitas E; Mohr P; Kuhn B; Hebeisen P; Wessel HP; Haap W; Ruf A; Benz J; Joseph C; Huber W; Sanchez RA; Paehler A; Benardeau A; Gubler M; Schott B; Tozzo E
Bioorg Med Chem Lett; 2010 Jan; 20(2):594-9. PubMed ID: 19969452
[TBL] [Abstract][Full Text] [Related]
12. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
[TBL] [Abstract][Full Text] [Related]
13. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
Wrobel J; Li Z; Dietrich A; McCaleb M; Mihan B; Sredy J; Sullivan D
J Med Chem; 1998 Mar; 41(7):1084-91. PubMed ID: 9544208
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anthelmintic activity of carbamates derived from imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b]thiazole.
Marin A; Valls N; Berenguer FJ; Alonso MT; Ramon Martinez A; Mercedes Martinez M; Elguero J
Farmaco; 1992 Jan; 47(1):63-75. PubMed ID: 1616578
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.
Dang Q; Liu Y; Cashion DK; Kasibhatla SR; Jiang T; Taplin F; Jacintho JD; Li H; Sun Z; Fan Y; DaRe J; Tian F; Li W; Gibson T; Lemus R; van Poelje PD; Potter SC; Erion MD
J Med Chem; 2011 Jan; 54(1):153-65. PubMed ID: 21126019
[TBL] [Abstract][Full Text] [Related]
16. [Imidazo(2,1-b)thiazole XII derivatives. Synthesis and research of immunoactivity in vitro on human T lymphocyte of 3-aroylmethyl and 2-aroyl-3-methyl(aryl)-5,6-dihydroimidaz o(2,1-b)thiazoles].
Robert JF; Hassanine A; Harraga S; Seilles E
Ann Pharm Fr; 1995; 53(6):261-71. PubMed ID: 8572506
[TBL] [Abstract][Full Text] [Related]
17. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and pharmacological evaluation of N-(4-mono and 4,5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators.
Li F; Zhu Q; Zhang Y; Feng Y; Leng Y; Zhang A
Bioorg Med Chem; 2010 Jun; 18(11):3875-84. PubMed ID: 20472448
[TBL] [Abstract][Full Text] [Related]
19. Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
Budriesi R; Ioan P; Locatelli A; Cosconati S; Leoni A; Ugenti MP; Andreani A; Di Toro R; Bedini A; Spampinato S; Marinelli L; Novellino E; Chiarini A
J Med Chem; 2008 Mar; 51(6):1592-600. PubMed ID: 18303827
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antihypertensive activity of imidazo[2,1-b]-thiazoles bearing a 2,6-dichlorophenyl group.
Andreani A; Rambaldi M; Locatelli A; Cristoni A; Malandrino S; Pifferi G
Acta Pharm Nord; 1992; 4(2):93-6. PubMed ID: 1388775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
